Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Nat Med

Retrieve available abstracts of 43 articles:
HTML format



Single Articles


    July 2021
  1. ALDRIDGE BB, Barros-Aguirre D, Barry CE 3rd, Bates RH, et al
    The Tuberculosis Drug Accelerator at year 10: what have we learned?
    Nat Med. 2021 Jul 5. pii: 10.1038/s41591-021-01442.
    PubMed    


    June 2021
  2. OGISHI M, Yang R, Aytekin C, Langlais D, et al
    Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child.
    Nat Med. 2021 Jun 28. pii: 10.1038/s41591-021-01388.
    PubMed     Abstract available


  3. PROCTOR DM, Dangana T, Sexton DJ, Fukuda C, et al
    Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility.
    Nat Med. 2021 Jun 21. pii: 10.1038/s41591-021-01383.
    PubMed     Abstract available


  4. GYGLI SM, Loiseau C, Jugheli L, Adamia N, et al
    Publisher Correction: Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacterium tuberculosis.
    Nat Med. 2021 Jun 1. pii: 10.1038/s41591-021-01417.
    PubMed    


    May 2021
  5. GYGLI SM, Loiseau C, Jugheli L, Adamia N, et al
    Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacteritum tuberculosis.
    Nat Med. 2021 May 24. pii: 10.1038/s41591-021-01358.
    PubMed     Abstract available


    April 2021
  6. NAKATSUJI T, Hata TR, Tong Y, Cheng JY, et al
    Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial.
    Nat Med. 2021;27:700-709.
    PubMed     Abstract available


    October 2020
  7. GUPTA RK, Calderwood CJ, Yavlinsky A, Krutikov M, et al
    Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
    Nat Med. 2020 Oct 19. pii: 10.1038/s41591-020-1076.
    PubMed     Abstract available


    July 2020
  8. ALLEN BM, Hiam KJ, Burnett CE, Venida A, et al
    Systemic dysfunction and plasticity of the immune macroenvironment in cancer models.
    Nat Med. 2020;26:1125-1134.
    PubMed     Abstract available


    June 2020
  9. THERON G, Limberis J, Venter R, Smith L, et al
    Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis.
    Nat Med. 2020 Jun 29. pii: 10.1038/s41591-020-0940.
    PubMed     Abstract available


    May 2020
  10. MANYAZEWAL T, Woldeamanuel Y, Blumberg HM, Fekadu A, et al
    The fight to end tuberculosis must not be forgotten in the COVID-19 outbreak.
    Nat Med. 2020 May 12. pii: 10.1038/s41591-020-0917.
    PubMed    


    April 2020
  11. ERNST CM, Braxton JR, Rodriguez-Osorio CA, Zagieboylo AP, et al
    Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae.
    Nat Med. 2020 Apr 13. pii: 10.1038/s41591-020-0825.
    PubMed     Abstract available


  12. NAGAO-KITAMOTO H, Leslie JL, Kitamoto S, Jin C, et al
    Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota.
    Nat Med. 2020;26:608-617.
    PubMed     Abstract available


    February 2020
  13. ORDONEZ AA, Wang H, Magombedze G, Ruiz-Bedoya CA, et al
    Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions.
    Nat Med. 2020 Feb 17. pii: 10.1038/s41591-020-0770.
    PubMed     Abstract available


    January 2020
  14. ZHAI B, Ola M, Rolling T, Tosini NL, et al
    High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis.
    Nat Med. 2020;26:59-64.
    PubMed     Abstract available


    November 2019
  15. YELIN I, Flett KB, Merakou C, Mehrotra P, et al
    Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients.
    Nat Med. 2019;25:1728-1732.
    PubMed     Abstract available


  16. HAAK BW, Wiersinga WJ
    The differing roles of lactobacilli in critical illness.
    Nat Med. 2019;25:1651-1653.
    PubMed    


    October 2019
  17. LEV-SAGIE A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, et al
    Vaginal microbiome transplantation in women with intractable bacterial vaginosis.
    Nat Med. 2019;25:1500-1504.
    PubMed     Abstract available


    September 2019
  18. BHUTTA ZA
    The benefits and risks of mass antibiotic use for reducing child mortality.
    Nat Med. 2019;25:1332-1334.
    PubMed    


  19. DOAN T, Hinterwirth A, Worden L, Arzika AM, et al
    Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution.
    Nat Med. 2019;25:1370-1376.
    PubMed     Abstract available


    August 2019
  20. MULLER WJ, Mulkey SB
    Lessons about early neurodevelopment in children exposed to ZIKV in utero.
    Nat Med. 2019;25:1192-1193.
    PubMed    


  21. NIELSEN-SAINES K, Brasil P, Kerin T, Vasconcelos Z, et al
    Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children.
    Nat Med. 2019;25:1213-1217.
    PubMed     Abstract available


    July 2019
  22. YELIN I, Snitser O, Novich G, Katz R, et al
    Personal clinical history predicts antibiotic resistance of urinary tract infections.
    Nat Med. 2019 Jul 4. pii: 10.1038/s41591-019-0503.
    PubMed     Abstract available


  23. DIDELOT X, Pouwels KB
    Machine-learning-assisted selection of antibiotic prescription.
    Nat Med. 2019;25:1033-1034.
    PubMed    


  24. GIBANI MM, Jones E, Barton A, Jin C, et al
    Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model.
    Nat Med. 2019;25:1082-1088.
    PubMed     Abstract available


    June 2019
  25. LU LL, Smith MT, Yu KKQ, Luedemann C, et al
    Publisher Correction: IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure.
    Nat Med. 2019 Jun 20. pii: 10.1038/s41591-019-0519.
    PubMed     Abstract available


  26. GOPALAKRISHNA KP, Macadangdang BR, Rogers MB, Tometich JT, et al
    Maternal IgA protects against the development of necrotizing enterocolitis in preterm infants.
    Nat Med. 2019 Jun 17. pii: 10.1038/s41591-019-0480.
    PubMed     Abstract available


  27. STOWER H
    Rapid neonatal diagnosis.
    Nat Med. 2019;25:877.
    PubMed    


  28. KAUSHIK K
    Defining the path of a physician-scientist.
    Nat Med. 2019;25:867.
    PubMed    


    May 2019
  29. LU LL, Smith MT, Yu KKQ, Luedemann C, et al
    IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure.
    Nat Med. 2019 May 20. pii: 10.1038/s41591-019-0441.
    PubMed     Abstract available


  30. STOWER H
    Therapeutic selfies.
    Nat Med. 2019;25:710.
    PubMed    


  31. DEDRICK RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, et al
    Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.
    Nat Med. 2019;25:730-733.
    PubMed     Abstract available


  32. SUEZ J, Zmora N, Segal E, Elinav E, et al
    The pros, cons, and many unknowns of probiotics.
    Nat Med. 2019;25:716-729.
    PubMed     Abstract available


    February 2019
  33. LADNER JT, Grubaugh ND, Pybus OG, Andersen KG, et al
    Precision epidemiology for infectious disease control.
    Nat Med. 2019;25:206-211.
    PubMed     Abstract available


    January 2019
  34. SCRIBA TJ, Nemes E
    Protection against tuberculosis by mucosal BCG administration.
    Nat Med. 2019 Jan 28. pii: 10.1038/s41591-019-0347.
    PubMed    


  35. DIJKMAN K, Sombroek CC, Vervenne RAW, Hofman SO, et al
    Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques.
    Nat Med. 2019 Jan 21. pii: 10.1038/s41591-018-0319.
    PubMed     Abstract available


    November 2018
  36. IMPERIAL MZ, Nahid P, Phillips PPJ, Davies GR, et al
    Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.
    Nat Med. 2018 Nov 14. pii: 10.1038/s41591-018-0294.
    PubMed     Abstract available


  37. CHURCHYARD GJ
    A stratified approach to tuberculosis treatment.
    Nat Med. 2018;24:1639-1641.
    PubMed    


  38. FARRELL A
    A vaccine for tuberculosis.
    Nat Med. 2018;24:1637.
    PubMed    


  39. IMPERIAL MZ, Nahid P, Phillips PPJ, Davies GR, et al
    A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.
    Nat Med. 2018;24:1708-1715.
    PubMed     Abstract available


    October 2018
  40. WAGNER DL, Amini L, Wendering DJ, Burkhardt LM, et al
    High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population.
    Nat Med. 2018 Oct 29. pii: 10.1038/s41591-018-0204.
    PubMed     Abstract available


    February 2018
  41. CARPENTER SM, Behar SM
    A new vaccine for tuberculosis in rhesus macaques.
    Nat Med. 2018;24:124-126.
    PubMed    


    January 2018
  42. HANSEN SG, Zak DE, Xu G, Ford JC, et al
    Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.
    Nat Med. 2018 Jan 15. pii: nm.4473. doi: 10.1038/nm.4473.
    PubMed     Abstract available


    December 2017
  43. MALHERBE ST, Shenai S, Ronacher K, Loxton AG, et al
    Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure.
    Nat Med. 2017;23:1499.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: